Nike's North America Glimmer Tempered by China Drag and Tariff Overhang

What happened

A recent article highlights that Nike's North America sell-through grew across all channels in February for the first time in two years, offering a glimmer of demand recovery. However, the same report warns that Greater China revenue is expected to fall about 20% in the current quarter, underscoring persistent regional weakness. The latest DeepValue master report confirms the mixed picture: while wholesale is growing, Nike Direct is declining on traffic losses, and tariffs remain the dominant gross-margin headwind, with inventory liquidation ongoing through end-2026. The stock trades at $45.2, near decade lows, reflecting deep skepticism that management can execute the cleanup and restore margins on time. Upcoming FY26 Q4 earnings on June 30 are the critical near-term catalyst to verify whether tariff pressure is truly abating and the inventory reset stays on schedule.

Implication

The stock's valuation at $45.2 already prices in a pessimistic scenario, but the risk of extended promotions and China weakness through fiscal 2027 keeps a 'WAIT' stance appropriate. If the June 30 earnings call reaffirms the end-December 2026 cleanup deadline and shows gross margin stabilization, the stock could re-rate toward the $54 bull case. Conversely, any delay or deepening of tariff pressure could push the stock to $36. The early North America sell-through growth is a positive but isolated signal; it does not yet shift the fundamental dependency on tariff mitigation and inventory clearance. Focus on management's tone regarding China trajectory and the timeline for margin inflection; near-term upside is capped absent clear evidence of operational improvement.

Thesis delta

The positive North America sell-through growth provides a potential demand floor but does not alter the core thesis that margin recovery hinges on tariff mitigation and inventory clearance. The key shift is that the North America signal offers a modest upside risk to revenue, yet the persistent China drag and tariff overhang mean the turnaround timeline remains uncertain. The thesis still depends on FY26 Q4 confirmation of a gross-margin expansion path in FY27 Q2.